世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

使い捨て内視鏡の市場規模、シェア、動向分析レポート:タイプ別(腹腔鏡、関節鏡)、エンドユース別(病院、外来施設)、地域別、セグメント別予測、2024年~2030年


Disposable Endoscopes Market Size, Share & Trends Analysis Report By Type (Laparoscopes, Arthroscopes), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030

使い捨て内視鏡市場の成長と動向 Grand View Research, Incの最新レポートによると、世界の使い捨て内視鏡市場規模は2030年までに73億2000万米ドルに達すると予測され、2024年から2030年までのCAGRは17.0%で... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年12月6日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
150 英語

1~3営業日


 

サマリー

使い捨て内視鏡市場の成長と動向

Grand View Research, Incの最新レポートによると、世界の使い捨て内視鏡市場規模は2030年までに73億2000万米ドルに達すると予測され、2024年から2030年までのCAGRは17.0%で成長すると予測されている。デバイス関連の感染リスクを排除するためのシングルユース内視鏡に対する需要の高まりは、世界市場の成長を促進する主要因である。さらに、低侵襲処置に対する患者の嗜好の高まり、支持的な規制枠組み、先進国における有利な償還政策が市場成長の原動力となっている。さらに、医療インフラの強化や内視鏡検査の研究促進に特化した政府や組織からの投資、資金、助成金の増加が市場成長に寄与している。

汚染された内視鏡が原因で院内感染の発生率が増加しており、これが市場における使い捨て内視鏡の需要を促進する主な要因となっている。American Journal of Infection Control誌によると、2018年3月、内視鏡の49%近くが再処理中に水分を保持していた。また、内視鏡サンプルからは71%の微生物増殖が検出され、患者の感染リスクを高めている。再利用可能な内視鏡は、使用中に微生物、血液、体内分泌物から汚染されるリスクが高い。これらの感染は主に、内視鏡の再処理の失敗、規制ガイドラインの不遵守、欠陥機器の使用により発生する。

技術の進歩は使い捨て内視鏡機器の分野に大きな影響を与え、技術革新を促進し、患者ケアを向上させた。これらの進歩は、より高度で洗練された使い捨て内視鏡の開発につながり、強化された画像処理能力、改善された操作性、使いやすさを提供している。例えば、高解像度カメラと高度な光学系を統合することで、より鮮明でクリアな画像が得られ、正確な診断と治療に役立っている。

部品の小型化により、より小型で柔軟な内視鏡が誕生し、狭く複雑な解剖学的構造へのアクセスが容易になった。さらに、材料や製造技術の進歩により、費用対効果に優れ、信頼性が高く、患者にとって安全な使い捨て内視鏡器具が製造されるようになった。

さらに、機器関連の感染リスクを排除するための使い捨て内視鏡に対する需要の高まりは、世界市場の成長を促進する重要な要因となっている。さらに、低侵襲処置に対する患者の嗜好の高まり、支持的な規制枠組み、先進国における有利な償還政策が市場を牽引している。さらに、医療インフラを強化し、内視鏡検査の研究を推進するための政府や組織からの投資、資金、助成金の増加が市場成長に寄与している。このような動きは、市場に有利な成長見通しを生み出している。

使い捨て内視鏡市場レポートハイライト

- タイプ別では、呼吸器系疾患の負担が大きいこと、疾患診断のための内視鏡検査の採用が多いことから、気管支鏡セグメントが最大の収益シェアを占めている。

- 膀胱鏡セグメントは、イメージング技術の進歩と尿路結石の増加により、最も速いCAGRを記録すると予測されている。

- 医療インフラの整備と低侵襲手技の採用増加により、2023年には外来患者施設が最大市場を占める

- アジア太平洋地域は、高い疾病負担の中でエンドユーザーからの需要が高く、市場参入企業による様々な戦略的合意により、予測期間中に最も速いCAGRを示すと予想される。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.1.1. Approach: Commodity flow approach
1.7. Research Assumption
1.8. List of Secondary Sources
1.9. List of Abbreviation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
1.10.3. Objective 3
1.10.4. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Competitive Insights
Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase in incidence of target disease
3.2.1.2. Technological advancements
3.2.1.3. Increased use of disposable endoscopes
3.2.1.4. Increasing trend of minimally invasive procedures
3.2.2. Market restraint analysis
3.2.2.1. Dearth of skilled professional
3.2.2.2. Product recalls and failures
3.3. Penetration & Growth Prospect Mapping
3.4. Mechanical Ventilators: Market Analysis Tools
3.4.1. Industry analysis - Porter’s
3.4.2. PESTEL analysis
3.5. Regulatory Framework
Chapter 4. Disposable Endoscopes Market Segment Analysis, By Type
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Disposable Endoscopes Market, By Type, 2016 to 2030
4.5. Market Size & Forecast and Trend Analysis, 2016 to 2030
4.5.1. Laparoscopes
4.5.1.1. Laparoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.2. Arthroscopes
4.5.2.1. Arthroscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.3. Ureteroscopes
4.5.3.1. Ureteroscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.4. Cystoscopes
4.5.4.1. Cystoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.5. Gynecology Endoscopes
4.5.5.1. Gynecology endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.6. Neuroendoscopes
4.5.6.1. Neuroemdoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.7. Bronchoscopes
4.5.7.1. Bronchoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.8. Hysteroscopes
4.5.8.1. Hysteroscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.9. Laryngoscopes
4.5.9.1. Laryngoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.10. Otoscopes
4.5.10.1. Bronchoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.11. Sigmoidoscopes
4.5.11.1. Sigmoidoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.12. Duodenoscopes
4.5.12.1. Duodenoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.13. Nasopharyngoscopes
4.5.13.1. Nasopharyngoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.14. Rhinoscopes
4.5.14.1. Rhonoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.15. Colonoscopes
4.5.15.1. Colonoscopes market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 5. Disposable Endoscopes Market Segment Analysis, By End-use, 2016 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Interphase Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Disposable Endoscopes Market, By End-use, 2016 to 2030
5.5. Market Size & Forecast and Trend Analysis, 2016 to 2030
5.5.1. Outpatient Facilities
5.5.1.1. Outpatient Facilities market estimates and forecast, 2016 - 2030 (USD Million)
5.5.2. Hospitals
5.5.2.1. Hospitals market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 6. Disposable Endoscopes Market Segment Analysis, By Region, 2016 - 2030 (USD Million)
6.1. Definition and Scope
6.2. Regional Market Share Analysis, 2023 & 2030
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. SWOT Analysis
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. Market Size & Forecast, Revenue and Trend Analysis, 2023 to 2030
6.6.1. North America
6.6.1.1. North America disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.1.2. U.S.
6.6.1.2.1. Key country dynamics
6.6.1.2.2. Competitive scenario
6.6.1.2.3. Regulatory framework
6.6.1.2.4. Reimbursement scenario
6.6.1.2.5. U.S. market estimates and forecast, 2016 - 2030 (USD Million)
6.6.1.3. Canada
6.6.1.3.1. Key country dynamics
6.6.1.3.2. Competitive scenario
6.6.1.3.3. Regulatory framework
6.6.1.3.4. Reimbursement scenario
6.6.1.3.5. Canada market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2. Europe
6.6.2.1. Europe disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.2. UK
6.6.2.2.1. Key country dynamics
6.6.2.2.2. Competitive scenario
6.6.2.2.3. Regulatory framework
6.6.2.2.4. Reimbursement scenario
6.6.2.2.5. UK market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.3. Germany
6.6.2.3.1. Key country dynamics
6.6.2.3.2. Competitive scenario
6.6.2.3.3. Regulatory framework
6.6.2.3.4. Reimbursement scenario
6.6.2.3.5. Germany market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.4. Spain
6.6.2.4.1. Key country dynamics
6.6.2.4.2. Competitive scenario
6.6.2.4.3. Regulatory framework
6.6.2.4.4. Reimbursement scenario
6.6.2.4.5. Spain market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.5. France
6.6.2.5.1. Key country dynamics
6.6.2.5.2. Competitive scenario
6.6.2.5.3. Regulatory framework
6.6.2.5.4. Reimbursement scenario
6.6.2.5.5. France market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.6. Italy
6.6.2.6.1. Key country dynamics
6.6.2.6.2. Competitive scenario
6.6.2.6.3. Regulatory framework
6.6.2.6.4. Reimbursement scenario
6.6.2.6.5. Italy market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.7. Denmark
6.6.2.7.1. Key country dynamics
6.6.2.7.2. Competitive scenario
6.6.2.7.3. Regulatory framework
6.6.2.7.4. Reimbursement scenario
6.6.2.7.5. Denmark market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.8. Norway
6.6.2.8.1. Key country dynamics
6.6.2.8.2. Competitive scenario
6.6.2.8.3. Regulatory framework
6.6.2.8.4. Reimbursement scenario
6.6.2.8.5. Norway market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.9. Sweden
6.6.2.9.1. Key country dynamics
6.6.2.9.2. Competitive scenario
6.6.2.9.3. Regulatory framework
6.6.2.9.4. Reimbursement scenario
6.6.2.9.5. Sweden market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3. Asia Pacific
6.6.3.1. Asia Pacific disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.2. Japan
6.6.3.2.1. Key country dynamics
6.6.3.2.2. Competitive scenario
6.6.3.2.3. Regulatory framework
6.6.3.2.4. Reimbursement scenario
6.6.3.2.5. Japan market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.3. China
6.6.3.3.1. Key country dynamics
6.6.3.3.2. Competitive scenario
6.6.3.3.3. Regulatory framework
6.6.3.3.4. Reimbursement scenario
6.6.3.3.5. China market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.4. India
6.6.3.4.1. Key country dynamics
6.6.3.4.2. Competitive scenario
6.6.3.4.3. Regulatory framework
6.6.3.4.4. Reimbursement scenario
6.6.3.4.5. India market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.5. South Korea
6.6.3.5.1. Key country dynamics
6.6.3.5.2. Competitive scenario
6.6.3.5.3. Regulatory framework
6.6.3.5.4. Reimbursement scenario
6.6.3.5.5. South Korea market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.6. Australia
6.6.3.6.1. Key country dynamics
6.6.3.6.2. Competitive scenario
6.6.3.6.3. Regulatory framework
6.6.3.6.4. Reimbursement scenario
6.6.3.6.5. Australia market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.7. Thailand
6.6.3.7.1. Key country dynamics
6.6.3.7.2. Competitive scenario
6.6.3.7.3. Regulatory framework
6.6.3.7.4. Reimbursement scenario
6.6.3.7.5. Thailand market estimates and forecast, 2016 - 2030 (USD Million)
6.6.4. Latin America
6.6.4.1. Latin America disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.4.2. Brazil
6.6.4.2.1. Key country dynamics
6.6.4.2.2. Competitive scenario
6.6.4.2.3. Regulatory framework
6.6.4.2.4. Reimbursement scenario
6.6.4.2.5. Brazil market estimates and forecast, 2016 - 2030 (USD Million)
6.6.4.3. Mexico
6.6.4.3.1. Key country dynamics
6.6.4.3.2. Competitive scenario
6.6.4.3.3. Regulatory framework
6.6.4.3.4. Reimbursement scenario
6.6.4.3.5. Mexico market estimates and forecast, 2016 - 2030 (USD Million)
6.6.4.4. Argentina
6.6.4.4.1. Key country dynamics
6.6.4.4.2. Competitive scenario
6.6.4.4.3. Regulatory framework
6.6.4.4.4. Reimbursement scenario
6.6.4.4.5. Argentina market estimates and forecast, 2016 - 2030 (USD Million)
6.6.5. MEA
6.6.5.1. MEA disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.5.2. South Africa
6.6.5.2.1. Key country dynamics
6.6.5.2.2. Competitive scenario
6.6.5.2.3. Regulatory framework
6.6.5.2.4. Reimbursement scenario
6.6.5.2.5. South Africa market estimates and forecast, 2016 - 2030 (USD Million)
6.6.5.3. Saudi Arabia
6.6.5.3.1. Key country dynamics
6.6.5.3.2. Competitive scenario
6.6.5.3.3. Regulatory framework
6.6.5.3.4. Reimbursement scenario
6.6.5.3.5. Saudi Arabia market estimates and forecast, 2016 - 2030 (USD Million)
6.6.5.4. UAE
6.6.5.4.1. Key country dynamics
6.6.5.4.2. Competitive scenario
6.6.5.4.3. Regulatory framework
6.6.5.4.4. Reimbursement scenario
6.6.5.4.5. UAE market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 7. Disposable Endoscopes Market - Competitive Analysis
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.1.1. Heat map analysis
7.1.2. Major deals and strategic alliances analysis
7.2. Company Categorization
7.2.1. Innovators
7.2.2. Market lenders
7.3. Vendors Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.4. Public Companies
7.4.1. Competitive dashboard analysis
7.4.1.1. Market differentiators
7.5. Private Companies
7.5.1. List of key emerging companies
7.6. Company Profiles
7.6.1. Ambu A/S
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiative
7.6.2. Boston Scientific Corporation
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiative
7.6.3. OBP Surgical Corporation
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiative
7.6.4. Co-opersurgical, Inc.
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiative
7.6.5. Flexicare Medical Limited
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiative
7.6.6. Welch Allyn (Hill Rom)
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiative
7.6.7. HOYA Corporation
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiative
7.6.8. KARL STORZ
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiative
7.6.9. Olympus Corporation
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiative
7.6.10. OTU Medical
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

Disposable Endoscopes Market Growth & Trends

The global disposable endoscopes market size is anticipated to reach USD 7.32 billion by 2030 and it is projected to grow at a CAGR of 17.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising demand for single-use endoscopes to eliminate risk of device-related infection is a key factor driving the global market growth. Moreover, market growth is driven by growing preference of patients for minimally invasive procedures, supportive regulatory framework, and favorable reimbursement policies in developed nations. Furthermore, increasing investments, funds, and grants from governments & organizations dedicated to enhancing healthcare infrastructure and advancing research in endoscopy are contributing to market growth.

The incidence of nosocomial infections is increasing due to contaminated endoscopes, a major factor driving the demand for disposable endoscopes in the market. According to the American Journal of Infection Control, in March 2018, nearly 49% of the endoscopes retained moisture during reprocessing. In addition, 71% of microbial growth was detected in endoscope samples, increasing the risk of infections in patients. Reusable endoscopes pose a high risk of contamination from microorganisms, blood, and body secretions during use. These transmissions mainly occur due to endoscopic reprocessing failures, noncompliance with regulatory guidelines, and the use of defective equipment.

Technological advancements significantly impacted the field of disposable endoscopic devices, driving innovation and improving patient care. These advancements have led to the development of more advanced and sophisticated disposable endoscopes, offering enhanced imaging capabilities, improved maneuverability, and ease of use. For instance, integrating high-definition cameras and advanced optics resulted in sharper & clearer images, aiding in accurate diagnosis and treatment.

The miniaturization of components created smaller and more flexible endoscopes, enabling easier access to narrow & complex anatomical structures. Moreover, advancements in materials and manufacturing techniques led to the production of disposable endoscopic devices that are cost-effective, reliable, and safe for patients.

Moreover, rising demand for single-use endoscopes to eliminate the risk of device-related infection is a key factor driving the global market growth. Moreover, the market is driven by the growing preference of patients for minimally invasive procedures, supportive regulatory framework, and favorable reimbursement policies in developed nations. Furthermore, increasing investments, funds, and grants from governments & organizations dedicated to enhancing healthcare infrastructure and advancing research in endoscopy are contributing to market growth. These developments have created lucrative growth prospects in the market.

Disposable Endoscopes Market Report Highlights

• Based on type, the bronchoscopes segment held the largest revenue share owing to a high burden of respiratory conditions and high adoption of endoscopy procedures for condition diagnosis

• The cystoscopes segment is anticipated to register the fastest CAGR because of technological advancements in imaging techniques and increasing incidence of UTIs

• The outpatient facilities segment held the largest market in 2023 due to development in healthcare infrastructure and growth in adoption of minimally invasive procedures

• Asia Pacific is expected to exhibit the fastest CAGR over the forecast period due to high demand from end users amidst high disease burden and various strategic agreements by market players



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.1.1. Approach: Commodity flow approach
1.7. Research Assumption
1.8. List of Secondary Sources
1.9. List of Abbreviation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
1.10.3. Objective 3
1.10.4. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Competitive Insights
Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase in incidence of target disease
3.2.1.2. Technological advancements
3.2.1.3. Increased use of disposable endoscopes
3.2.1.4. Increasing trend of minimally invasive procedures
3.2.2. Market restraint analysis
3.2.2.1. Dearth of skilled professional
3.2.2.2. Product recalls and failures
3.3. Penetration & Growth Prospect Mapping
3.4. Mechanical Ventilators: Market Analysis Tools
3.4.1. Industry analysis - Porter’s
3.4.2. PESTEL analysis
3.5. Regulatory Framework
Chapter 4. Disposable Endoscopes Market Segment Analysis, By Type
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. Global Disposable Endoscopes Market, By Type, 2016 to 2030
4.5. Market Size & Forecast and Trend Analysis, 2016 to 2030
4.5.1. Laparoscopes
4.5.1.1. Laparoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.2. Arthroscopes
4.5.2.1. Arthroscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.3. Ureteroscopes
4.5.3.1. Ureteroscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.4. Cystoscopes
4.5.4.1. Cystoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.5. Gynecology Endoscopes
4.5.5.1. Gynecology endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.6. Neuroendoscopes
4.5.6.1. Neuroemdoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.7. Bronchoscopes
4.5.7.1. Bronchoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.8. Hysteroscopes
4.5.8.1. Hysteroscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.9. Laryngoscopes
4.5.9.1. Laryngoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.10. Otoscopes
4.5.10.1. Bronchoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.11. Sigmoidoscopes
4.5.11.1. Sigmoidoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.12. Duodenoscopes
4.5.12.1. Duodenoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.13. Nasopharyngoscopes
4.5.13.1. Nasopharyngoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.14. Rhinoscopes
4.5.14.1. Rhonoscopes market estimates and forecast, 2016 - 2030 (USD Million)
4.5.15. Colonoscopes
4.5.15.1. Colonoscopes market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 5. Disposable Endoscopes Market Segment Analysis, By End-use, 2016 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Interphase Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. Global Disposable Endoscopes Market, By End-use, 2016 to 2030
5.5. Market Size & Forecast and Trend Analysis, 2016 to 2030
5.5.1. Outpatient Facilities
5.5.1.1. Outpatient Facilities market estimates and forecast, 2016 - 2030 (USD Million)
5.5.2. Hospitals
5.5.2.1. Hospitals market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 6. Disposable Endoscopes Market Segment Analysis, By Region, 2016 - 2030 (USD Million)
6.1. Definition and Scope
6.2. Regional Market Share Analysis, 2023 & 2030
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. SWOT Analysis
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. Market Size & Forecast, Revenue and Trend Analysis, 2023 to 2030
6.6.1. North America
6.6.1.1. North America disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.1.2. U.S.
6.6.1.2.1. Key country dynamics
6.6.1.2.2. Competitive scenario
6.6.1.2.3. Regulatory framework
6.6.1.2.4. Reimbursement scenario
6.6.1.2.5. U.S. market estimates and forecast, 2016 - 2030 (USD Million)
6.6.1.3. Canada
6.6.1.3.1. Key country dynamics
6.6.1.3.2. Competitive scenario
6.6.1.3.3. Regulatory framework
6.6.1.3.4. Reimbursement scenario
6.6.1.3.5. Canada market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2. Europe
6.6.2.1. Europe disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.2. UK
6.6.2.2.1. Key country dynamics
6.6.2.2.2. Competitive scenario
6.6.2.2.3. Regulatory framework
6.6.2.2.4. Reimbursement scenario
6.6.2.2.5. UK market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.3. Germany
6.6.2.3.1. Key country dynamics
6.6.2.3.2. Competitive scenario
6.6.2.3.3. Regulatory framework
6.6.2.3.4. Reimbursement scenario
6.6.2.3.5. Germany market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.4. Spain
6.6.2.4.1. Key country dynamics
6.6.2.4.2. Competitive scenario
6.6.2.4.3. Regulatory framework
6.6.2.4.4. Reimbursement scenario
6.6.2.4.5. Spain market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.5. France
6.6.2.5.1. Key country dynamics
6.6.2.5.2. Competitive scenario
6.6.2.5.3. Regulatory framework
6.6.2.5.4. Reimbursement scenario
6.6.2.5.5. France market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.6. Italy
6.6.2.6.1. Key country dynamics
6.6.2.6.2. Competitive scenario
6.6.2.6.3. Regulatory framework
6.6.2.6.4. Reimbursement scenario
6.6.2.6.5. Italy market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.7. Denmark
6.6.2.7.1. Key country dynamics
6.6.2.7.2. Competitive scenario
6.6.2.7.3. Regulatory framework
6.6.2.7.4. Reimbursement scenario
6.6.2.7.5. Denmark market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.8. Norway
6.6.2.8.1. Key country dynamics
6.6.2.8.2. Competitive scenario
6.6.2.8.3. Regulatory framework
6.6.2.8.4. Reimbursement scenario
6.6.2.8.5. Norway market estimates and forecast, 2016 - 2030 (USD Million)
6.6.2.9. Sweden
6.6.2.9.1. Key country dynamics
6.6.2.9.2. Competitive scenario
6.6.2.9.3. Regulatory framework
6.6.2.9.4. Reimbursement scenario
6.6.2.9.5. Sweden market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3. Asia Pacific
6.6.3.1. Asia Pacific disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.2. Japan
6.6.3.2.1. Key country dynamics
6.6.3.2.2. Competitive scenario
6.6.3.2.3. Regulatory framework
6.6.3.2.4. Reimbursement scenario
6.6.3.2.5. Japan market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.3. China
6.6.3.3.1. Key country dynamics
6.6.3.3.2. Competitive scenario
6.6.3.3.3. Regulatory framework
6.6.3.3.4. Reimbursement scenario
6.6.3.3.5. China market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.4. India
6.6.3.4.1. Key country dynamics
6.6.3.4.2. Competitive scenario
6.6.3.4.3. Regulatory framework
6.6.3.4.4. Reimbursement scenario
6.6.3.4.5. India market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.5. South Korea
6.6.3.5.1. Key country dynamics
6.6.3.5.2. Competitive scenario
6.6.3.5.3. Regulatory framework
6.6.3.5.4. Reimbursement scenario
6.6.3.5.5. South Korea market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.6. Australia
6.6.3.6.1. Key country dynamics
6.6.3.6.2. Competitive scenario
6.6.3.6.3. Regulatory framework
6.6.3.6.4. Reimbursement scenario
6.6.3.6.5. Australia market estimates and forecast, 2016 - 2030 (USD Million)
6.6.3.7. Thailand
6.6.3.7.1. Key country dynamics
6.6.3.7.2. Competitive scenario
6.6.3.7.3. Regulatory framework
6.6.3.7.4. Reimbursement scenario
6.6.3.7.5. Thailand market estimates and forecast, 2016 - 2030 (USD Million)
6.6.4. Latin America
6.6.4.1. Latin America disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.4.2. Brazil
6.6.4.2.1. Key country dynamics
6.6.4.2.2. Competitive scenario
6.6.4.2.3. Regulatory framework
6.6.4.2.4. Reimbursement scenario
6.6.4.2.5. Brazil market estimates and forecast, 2016 - 2030 (USD Million)
6.6.4.3. Mexico
6.6.4.3.1. Key country dynamics
6.6.4.3.2. Competitive scenario
6.6.4.3.3. Regulatory framework
6.6.4.3.4. Reimbursement scenario
6.6.4.3.5. Mexico market estimates and forecast, 2016 - 2030 (USD Million)
6.6.4.4. Argentina
6.6.4.4.1. Key country dynamics
6.6.4.4.2. Competitive scenario
6.6.4.4.3. Regulatory framework
6.6.4.4.4. Reimbursement scenario
6.6.4.4.5. Argentina market estimates and forecast, 2016 - 2030 (USD Million)
6.6.5. MEA
6.6.5.1. MEA disposable endoscopes market estimates and forecast, 2016 - 2030 (USD Million)
6.6.5.2. South Africa
6.6.5.2.1. Key country dynamics
6.6.5.2.2. Competitive scenario
6.6.5.2.3. Regulatory framework
6.6.5.2.4. Reimbursement scenario
6.6.5.2.5. South Africa market estimates and forecast, 2016 - 2030 (USD Million)
6.6.5.3. Saudi Arabia
6.6.5.3.1. Key country dynamics
6.6.5.3.2. Competitive scenario
6.6.5.3.3. Regulatory framework
6.6.5.3.4. Reimbursement scenario
6.6.5.3.5. Saudi Arabia market estimates and forecast, 2016 - 2030 (USD Million)
6.6.5.4. UAE
6.6.5.4.1. Key country dynamics
6.6.5.4.2. Competitive scenario
6.6.5.4.3. Regulatory framework
6.6.5.4.4. Reimbursement scenario
6.6.5.4.5. UAE market estimates and forecast, 2016 - 2030 (USD Million)
Chapter 7. Disposable Endoscopes Market - Competitive Analysis
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.1.1. Heat map analysis
7.1.2. Major deals and strategic alliances analysis
7.2. Company Categorization
7.2.1. Innovators
7.2.2. Market lenders
7.3. Vendors Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.4. Public Companies
7.4.1. Competitive dashboard analysis
7.4.1.1. Market differentiators
7.5. Private Companies
7.5.1. List of key emerging companies
7.6. Company Profiles
7.6.1. Ambu A/S
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiative
7.6.2. Boston Scientific Corporation
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiative
7.6.3. OBP Surgical Corporation
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiative
7.6.4. Co-opersurgical, Inc.
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiative
7.6.5. Flexicare Medical Limited
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiative
7.6.6. Welch Allyn (Hill Rom)
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiative
7.6.7. HOYA Corporation
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiative
7.6.8. KARL STORZ
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiative
7.6.9. Olympus Corporation
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiative
7.6.10. OTU Medical
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD(disposable)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る